APSIN 20MG TAB (20S
₨232Apsin 20mg Tablets reduce stomach acid production. They treat acid reflux, ulcers, and heartburn. Provide relief from acidity and protect the stomach lining.
Showing 169–180 of 3002 results
-
-
APSIN 40MG TAB (10S)
₨189Apsin 40mg Tablets treat severe acidity and ulcers. They block acid production and promote healing of the stomach lining. Relieve symptoms like heartburn and pain.
-
AQUAZOLE 20GM CREAM
₨240Aquazole 20gm Cream treats fungal skin infections. It relieves itching, redness, and scaling. Helps clear infections like ringworm and athlete’s foot.
-
ARBI 150MG TAB.
₨323.66ARBI 150MG Tablet contains Irbesartan, an angiotensin II receptor blocker (ARB) used for the management of high blood pressure (hypertension). It helps relax blood vessels, improving blood circulation and reducing the workload on the heart. ARBI is also effective in protecting kidney function in patients with type 2 diabetes and high blood pressure, lowering the…
-
ARBI 300MG TAB
₨500 -
ARBI 300MG TAB.
₨500Arbi 300mg Tablet contains Irbesartan, an angiotensin II receptor blocker (ARB) used to treat high blood pressure (hypertension) and to protect kidney function in patients with type 2 diabetes and hypertension. It works by relaxing blood vessels, making it easier for the heart to pump blood.
-
ARBI D 300/12.5MG TAB
₨581Arbi-D 300/12.5 mg is a fixed-dose combination tablet containing Irbesartan 300 mg + Hydrochlorothiazide 12.5 mg. Irbesartan is an angiotensin II receptor blocker (ARB) that lowers blood pressure by preventing angiotensin II from binding its receptor, leading to blood vessel relaxation and decreased resistance. Hydrochlorothiazide is a thiazide diuretic; it increases excretion of sodium and…
-
ARCEVA 20/120MG TAB
₨570.60Arceva 20/120mg Tablet is a combination antimalarial medicine containing Artemether (20mg) and Lumefantrine (120mg). It is used for the treatment of uncomplicated malaria, particularly malaria caused by Plasmodium falciparum. This combination works by killing malaria parasites at different stages of their life cycle, helping to clear the infection.
-
ARCEVA 40/240MG TAB
₨470.82ARCEVA 40/240MG Tablet is a combination medicine containing Telmisartan (40mg) and Valsartan (240mg). It is used for the effective management of high blood pressure (hypertension). By blocking the action of angiotensin II, both ingredients work together to relax blood vessels, improve blood flow, and reduce strain on the heart. This dual action helps in better…
-
ARCEVA 80/480MG TAB
₨588.50ARCEVA 80/480MG Tablet is a fixed-dose antimalarial combination of Artemether (80mg) and Lumefantrine (480mg). It is used for treating uncomplicated Plasmodium falciparum malaria, especially in cases where resistance to first-line drugs (such as chloroquine) is present. Artemether works quickly to reduce parasite load, while Lumefantrine has a longer half-life to eliminate remaining parasites and reduce…
-
ARCEVA DRY 15/90MG 30ML SYP
₨366.09Arceva Dry 15/90 mg Syrup is a pediatric formulation containing Artemether 15 mg and Lumefantrine 90 mg per 5 mL. It is used for the treatment of acute, uncomplicated malaria caused by Plasmodium falciparum, including drug-resistant strains. The syrup works by rapidly killing malaria parasites (artemether) and preventing their replication (lumefantrine), providing a complete dual-action therapy.
-
ARCEVA DS 30ML SYP
₨305.08Arceva DS 30 mL Syrup is a pediatric formulation containing Artemether 30 mg and Lumefantrine 180 mg per 5 mL. It is manufactured by Sami Pharmaceuticals and is used for the treatment of acute, uncomplicated malaria caused by Plasmodium falciparum, including cases resistant to chloroquine. Artemether is a rapid-acting antimalarial that disrupts the parasite’s digestive vacuole, inhibiting its metabolism…
End of content
End of content
The Categories provide a framework to which existing art information systems can be mapped and upon which new systems can be developed. In addition, the discussions in the CDWA identify vocabulary resources and descriptive practices that will make information residing in diverse systems both more compatible and more accessible.The use of the CDWA framework will contribute to the integrity and longevity of data and will facilitate its inevitable migration to new systems as informational technology continues to evolve. Above all, it will help to give end-users consistent, reliable access to information, regardless of the system in which it resides.
